This is read by an automated voice. Please report any issues or inconsistencies here. Antares, a Torrance-based startup focused on micronuclear reactor development, raised $96 million in a Series B ...

Antares, an advanced nuclear energy startup, announced the close of its $96-million Series B funding round, which was led by Shine Capital with participation from Alt Capital, Caffeinated, FiftyThree ...

Nuclear startup Antares said Tuesday it has raised $96 million in Series B funding as it pursues its small modular reactor design. The round, which was led by Shine Capital with participation from Alt ...

National, state and local leaders from Idaho were present for Antares Industries officially opening an office in Idaho Falls on Monday morning. Antares Industries (often referred to simply as Antares) ...

Good day, and thank you for standing by. Welcome to the conference call to discuss Crane NXT's agreement to acquire Antares Vision. [Operator Instructions]. Please be advised that today's conference ...

Shannon Silverman, an Astrophysicist at the Clay Center in Charleston West Virginia, guides us through the cosmos above West Virginia. In this episode she tells us about some of the summer's brightest ...

The company intends to introduce its inaugural product candidate into clinical trials by 2026. Credit: Komsan Loonprom/Shutterstock. Antares Therapeutics has secured $177m in a Series A financing ...

The team that steered a clinical-stage cancer drug to an acquisition by Eli Lilly is back at it again, unveiling a new venture supported by $177 million for a pipeline of precision medicines ...

– Advancing multiple programs across cancer and other serious diseases; plans to advance first new product candidate into the clinic in 2026 – – Series A financing co-led by Omega Funds, Atlas Venture ...

Antares Therapeutics has launched with $177 million in series A financing and a staff already at full speed, according to CEO Adam Friedman. The company is a spin-off of Scorpion Therapeutics, which ...